Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR142 | Q7Z601 | 4/20 | 0.40 |
| ▸ | CREBBP | Q92793 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.38 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.38 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.38 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1997496 | 0.86 | MEN1 (0.40) | HSD17B10KDM4EGRIN2DGRIN3BGRIN1 | |
| SCHEMBL1989631 | 0.81 | GRIN2D (0.46) | GPR142CREBBPHSD17B10KDM4EGRIN2D | |
| SCHEMBL4566908 | 0.78 | GPR142 (0.40) | GPR142CREBBPCYP3A4CYP2D6HSD17B10 | |
| SCHEMBL1990022 | 0.76 | HSD17B10 (0.40) | GPR142CREBBPCYP3A4CYP2D6HSD17B10 | |
| SCHEMBL1990956 | 0.73 | GSK3B (0.52) | — | |
| SCHEMBL1990957 | 0.73 | GSK3B (0.52) | — | |
| SCHEMBL6125959 | 0.72 | GRIN2D (0.60) | CYP3A4CYP2D6HSD17B10TSHRCYP2C19 | |
| Fumaric Acid SCHEMBL1988836 | 0.72 | GSK3B (0.46) | CYP3A4CYP2C19KDM4EALDH1A1 | |
| Maleic Acid SCHEMBL1988834 | 0.72 | GSK3B (0.46) | CYP3A4CYP2C19KDM4EALDH1A1 | |
| Maleic Acid SCHEMBL1988832 | 0.72 | GSK3B (0.46) | CYP3A4CYP2C19KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2077846-B1 | BENZOXAZEPINE COMPOUNDS, THEIR PREPARATION AND USE | PIRAMAL LIFE SCIENCES LTD (IN) | 2011-10-12 | — | — | EP | claimed |
| US-8263587-B2 | Benzoxazepine compounds, their preparation and use | PIRAMAL HEALTHCARE LIMITED (IN) | 2012-09-11 | — | — | US | disclosed |
| EP-2077846-B1 | BENZOXAZEPINE COMPOUNDS, THEIR PREPARATION AND USE | PIRAMAL LIFE SCIENCES LTD (IN) | 2011-10-12 | — | — | EP | disclosed |
| US-20110152247-A1 | BENZOXAZEPINE COMPOUNDS, THEIR PREPARATION AND USE | Piramal Enterprises Limited (IN) | 2011-06-23 | — | — | US | disclosed |
| EP-2077846-A2 | BENZOXAZEPINE COMPOUNDS, THEIR PREPARATION AND USE | Piramal Life Sciences Limited (IN) | 2009-07-15 | — | — | EP | disclosed |
| WO-2008053446-A2 | BENZOXAZEPINE COMPOUNDS, THEIR PREPARATION AND USE | PIRAMAL LIFE SCIENCES LIMITED (IN) | 2008-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152247-A1 | BENZOXAZEPINE COMPOUNDS, THEIR PREPARATION AND USE | GPR119, INSR, SLC5A1 | GPR142 850/4885CREBBP 439/4885CYP3A4 56/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.